A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect on Unassisted Erectile Function of the Early Use of Tadalafil 5 mg Once a Day and Tadalafil 20 mg On Demand Treatment for 9 Months in Subjects Undergoing Bilateral Nerve-Sparing Radical Prostatectomy.

Trial Profile

A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect on Unassisted Erectile Function of the Early Use of Tadalafil 5 mg Once a Day and Tadalafil 20 mg On Demand Treatment for 9 Months in Subjects Undergoing Bilateral Nerve-Sparing Radical Prostatectomy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2016

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Acronyms LVIK; REACTT
  • Sponsors Eli Lilly
  • Most Recent Events

    • 22 Aug 2014 Last checked against the European Clinical Trials Database record.
    • 13 Apr 2014 Results presented at the 29th Congress of the European Association of Urology.
    • 12 Oct 2012 Planned number of patients changed from 412 to 690 as reported by EudraCT.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top